{"schema_version":"secwatch.filing_event.v1","accession":"0001161697-22-000259","form_type":"8-K","ticker":"KRMD","cik":"0000704440","company_name":"KORU Medical Systems, Inc.","filed_at":"2022-05-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.414045+00:00","generated_at":"2026-06-25T10:34:05.257274+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Repro Med CFO Karen Fisher to resign June 30, 2022; Tom Adams named interim CFO","bullets":["CFO Karen Fisher resigns effective June 30, 2022; no disagreements with company.","Transition Agreement includes severance per existing employment agreement and $60,000 payment.","Tom Adams, VP of Financial Planning & Analysis since Nov 2021, will serve as interim CFO from July 1.","Adams has 20+ years med-tech/pharma finance experience, previously at Integra Life Sciences and Pfizer."],"urls":{"canonical":"https://secwatch.observer/filing/0001161697-22-000259","json":"https://secwatch.observer/filing/0001161697-22-000259.json","markdown":"https://secwatch.observer/filing/0001161697-22-000259.md","text":"https://secwatch.observer/filing/0001161697-22-000259.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/0001161697-22-000259-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T10:34:05.257274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a72afe0b6","claim":"Tom Adams was appointed as Interim Chief Financial Officer at KORU Medical Systems, Inc..","evidence_excerpt":"In the interim, the Company’s Vice President of Financial Planning and Analysis, Tom Adams, will serve as Interim Chief Financial Officer of the Company effective July 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/0001161697-22-000259-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"f76efb7de4","claim":"Karen Fisher departed as Chief Financial Officer at KORU Medical Systems, Inc..","evidence_excerpt":"As reported under Item 1.01 above, Karen Fisher, the Company’s Chief Financial Officer, will resign her employment effective as of June 30, 2022 to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000259/0001161697-22-000259-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resign"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}